Angiotensin‐converting enzyme inhibitors and risk of age‐related macular degeneration in individuals with hypertension

AIMS: Several observational studies have examined the potential protective effect of angiotensin‐converting enzyme inhibitor (ACE‐I) use on the risk of age‐related macular degeneration (AMD) and have reported contradictory results owing to confounding and time‐related biases. We aimed to assess the...

Descripción completa

Detalles Bibliográficos
Autores principales: Subramanian, Anuradhaa, Han, Diana, Braithwaite, Tasanee, Thayakaran, Rasiah, Zemedikun, Dawit T., Gokhale, Krishna M., Lee, Wen Hwa, Coker, Jesse, Keane, Pearse A., Denniston, Alastair K., Nirantharakumar, Krishnarajah, Azoulay, Laurent, Adderley, Nicola J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541840/
https://www.ncbi.nlm.nih.gov/pubmed/35474585
http://dx.doi.org/10.1111/bcp.15366

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541840/
https://www.ncbi.nlm.nih.gov/pubmed/35474585
http://dx.doi.org/10.1111/bcp.15366

Ejemplares similares